Literature DB >> 28951342

The impact of ethnicity, educational and economic status on the prescription of insulin therapeutic regimens and on glycemic control in patients with type 1 diabetes. A nationwide study in Brazil.

Marilia Brito Gomes1, Melanie Rodacki2, Elizabeth João Pavin3, Roberta Arnoldi Cobas1, João S Felicio4, Lenita Zajdenverg2, Carlos Antonio Negrato5.   

Abstract

AIMS: Establish the relationship between demographic, educational and economic status on insulin therapeutic regimens (ITRs) and on glycemic control in patients with type 1 diabetes.
METHODS: This was a cross-sectional, multicenter study with 1760 patients conducted between August 2011 and August 2014 in 10 Brazilian cities.
RESULTS: Patients were stratified according to ITRs as follows: only NPH insulin (group 1, n=80(4.5%)); only long-acting insulin analogs (group 2, n=6(0.3%)); continuous subcutaneous insulin infusion (CSII) (group 3, n=62(3.5%)); NPH plus regular insulin (group 4, n=710(40.3%)); NPH plus ultra-rapid insulin analogs (group 5, n=259(14.8%)); long-acting insulin analogs plus regular insulin (group 6, n=25(4.4%)) and long-acting plus ultra-rapid insulin analogs (group 7, n=618 (35.1%)). As group A (provided free of charge by the government) we considered groups 1 and 4, and as group B (obtained through lawsuit or out-of-pocket) groups 2, 3 and 7. Multivariate logistic analysis showed that independent variables related to group B were older age, more years of school attendance, higher economic status and ethnicity (Caucasians). The independent variables related to better glycemic control were older age, higher adherence to diet, higher frequency of self-monitoring of blood glucose, more years of school attendance and belonging to group B.
CONCLUSIONS: In Brazilian National Health Care System, prescriptions of insulin analogs or CSII are more frequent in Caucasian patients with type 1 diabetes, with higher economic status and more years ofschool attendance. Among these variables years of school attendance was the only one associated with better glycemic control.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Glycemic control; Insulin therapeutic regimens; Type 1 diabetes

Mesh:

Substances:

Year:  2017        PMID: 28951342     DOI: 10.1016/j.diabres.2017.09.013

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  9 in total

1.  Genomic ancestry as a risk factor for diabetic retinopathy in patients with type 1 diabetes from an admixed population: a nested case-control study in Brazil.

Authors:  Deborah Conte Santos; Laura Gomes Nunes de Melo; Marcela Haas Pizarro; Bianca S V Barros; Carlos Antonio Negrato; Luís Cristóvão Porto; Dayse A Silva; Karla Rezende Guerra Drummond; Luiza Harcar Muniz; Tessa Cerqueria Lemos Mattos; André Araújo Pinheiro; Felipe Mallmann; Franz Schubert Lopes Leal; Fernando Korn Malerbi; Paulo Henrique Morales; Marília Brito Gomes
Journal:  Acta Diabetol       Date:  2020-03-03       Impact factor: 4.280

2.  A Cross-Sectional Study of Quality of Life Among Brazilian Adults With Type 1 Diabetes Treated With Insulin Glargine: Findings and Implications.

Authors:  Paulo H R F Almeida; Brian Godman; Vania Dos Santos Nunes-Nogueira; Lívia L P de Lemos; Francisco de Assis Acúrcio; Augusto A Guerra-Junior; Vânia E de Araújo; Alessandra M Almeida; Juliana Alvares-Teodoro
Journal:  Clin Diabetes       Date:  2022

3.  Therapeutic play to teach children with type 1 diabetes insulin self-injection: A pilot trial in a developing country.

Authors:  Rebecca O La Banca; Lori M B Laffel; Lisa K Volkening; Valéria C Sparapani; Emilia C de Carvalho; Lucila C Nascimento
Journal:  J Spec Pediatr Nurs       Date:  2020-09-18       Impact factor: 1.260

4.  Impact of government-funded insulin pump programs on insulin pump use in Canada: a cross-sectional study using the National Diabetes Repository.

Authors:  Cimon Song; Gillian L Booth; Bruce A Perkins; Alanna Weisman
Journal:  BMJ Open Diabetes Res Care       Date:  2021-10

5.  Use of continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes mellitus: a systematic mapping review.

Authors:  Carolina Spinelli Alvarenga; Rebecca Ortiz La Banca; Rhyquelle Rhibna Neris; Valéria de Cássia Sparapani; Miguel Fuentealba-Torres; Denisse Cartagena-Ramos; Camila Lima Leal; Marcos Venicio Esper; Lucila Castanheira Nascimento
Journal:  BMC Endocr Disord       Date:  2022-02-19       Impact factor: 2.763

6.  Comparison of three insulin bolus calculators to increase time in range of glycemia in a group of poorly controlled adults Type 1 diabetes in a Brazilian public health service.

Authors:  Vanessa Araujo Montanari; Mônica Andrade Lima Gabbay; Sérgio Atala Dib
Journal:  Diabetol Metab Syndr       Date:  2022-09-13       Impact factor: 5.395

7.  Current epidemiology of diabetic retinopathy in patients with type 1 diabetes: a national multicenter study in Brazil.

Authors:  Laura Gomes Nunes Melo; Paulo Henrique Morales; Karla Rezende Guerra Drummond; Deborah Conte Santos; Marcela Haas Pizarro; Bianca Senger Vasconcelos Barros; Tessa Cerqueria Lemos Mattos; André Araújo Pinheiro; Felipe Mallmann; Franz Schubert Lopes Leal; Fernando Korn Malerbi; Marilia Brito Gomes
Journal:  BMC Public Health       Date:  2018-08-08       Impact factor: 3.295

8.  Low empowerment and diabetes regimen distress are related to HbA1c in low income type 1 diabetes patients in a Brazilian tertiary public hospital.

Authors:  M S V M Silveira; A Moura Neto; A C Sposito; L Siminerio; E J Pavin
Journal:  Diabetol Metab Syndr       Date:  2019-01-22       Impact factor: 3.320

9.  Relatively young T1D adults using fixed doses of insulin have higher diabetes distress levels in a sample of patients from a Brazilian tertiary hospital.

Authors:  M S V M Silveira; T G Bovi; E J Pavin
Journal:  Diabetol Metab Syndr       Date:  2019-12-12       Impact factor: 3.320

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.